TELA Bio Inc (TELA) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.57 is considered Undervalued compared with the five-year average of -4.25. The fair price of TELA Bio Inc (TELA) is between 2.12 to 6.58 according to relative valuation method. Compared to the current price of 0.91 USD , TELA Bio Inc By Undervalued By 57.15%.

Relative Value

Fair Zone

2.12-6.58

Current Price：0.91

57.15%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is TELA Bio Inc (TELA) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

TELA Bio Inc (TELA) has a current Price-to-Book (P/B) ratio of 29.54. Compared to its 3-year average P/B ratio of 14.45, the current P/B ratio is approximately 104.41% higher. Relative to its 5-year average P/B ratio of 7.24, the current P/B ratio is about 308.12% higher. TELA Bio Inc (TELA) has a Forward Free Cash Flow (FCF) yield of approximately -62.05%. Compared to its 3-year average FCF yield of -40.69%, the current FCF yield is approximately 52.52% lower. Relative to its 5-year average FCF yield of -31.91%, the current FCF yield is about 94.46% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for TELA competitors is 2.39, providing a benchmark for relative valuation. TELA Bio Inc Corp (TELA.O) exhibits a P/S ratio of 0.57, which is -76.05% above the industry average. Given its robust revenue growth of 9.14%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of TELA increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of TELA in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is TELA currently overvalued or undervalued?

What is TELA Bio Inc (TELA) fair value?

TELA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of TELA Bio Inc (TELA) is between 2.12 to 6.58 according to relative valuation method.

How does TELA's valuation metrics compare to the industry average?

The average P/S ratio for TELA's competitors is 2.39, providing a benchmark for relative valuation. TELA Bio Inc Corp (TELA) exhibits a P/S ratio of 0.57, which is -76.05% above the industry average. Given its robust revenue growth of 9.14%, this premium appears unsustainable.

What is the current P/B ratio for TELA Bio Inc (TELA) as of Mar 02 2026?

As of Mar 02 2026, TELA Bio Inc (TELA) has a P/B ratio of 29.54. This indicates that the market values TELA at 29.54 times its book value.

What is the current FCF Yield for TELA Bio Inc (TELA) as of Mar 02 2026?

As of Mar 02 2026, TELA Bio Inc (TELA) has a FCF Yield of -62.05%. This means that for every dollar of TELA Bio Inc's market capitalization, the company generates -62.05 cents in free cash flow.

What is the current Forward P/E ratio for TELA Bio Inc (TELA) as of Mar 02 2026?

As of Mar 02 2026, TELA Bio Inc (TELA) has a Forward P/E ratio of -1.82. This means the market is willing to pay $-1.82 for every dollar of TELA Bio Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for TELA Bio Inc (TELA) as of Mar 02 2026?

As of Mar 02 2026, TELA Bio Inc (TELA) has a Forward P/S ratio of 0.57. This means the market is valuing TELA at $0.57 for every dollar of expected revenue over the next 12 months.

TELA Valuation